StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

USANA Health Sciences r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $10.69M, down 7.6% from the year before. Over ten years it grew 5.2% a year on average. The highest annual figure on record is $11.57M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jan 3, 2026$10.69M-7.6%
FY2024Dec 28, 2024$11.57M+1.1%
FY2023Dec 30, 2023$11.45M-1.0%
FY2022Dec 31, 2022$11.56M+4.1%
FY2021Jan 1, 2022$11.11M+4.5%
FY2020Jan 2, 2021$10.63M+3.6%
FY2019Dec 28, 2019$10.26M+0.2%
FY2018Dec 29, 2018$10.24M+14.4%
FY2017Dec 30, 2017$8.95M+1.2%
FY2016Dec 31, 2016$8.84M+37.7%
FY2015Jan 2, 2016$6.42M+25.2%
FY2014Jan 3, 2015$5.13M+0.9%
FY2013Dec 28, 2013$5.08M+9.0%
FY2012Dec 29, 2012$4.66M+14.6%
FY2011Dec 31, 2011$4.07M+6.0%
FY2010Jan 1, 2011$3.84M–

More USANA Health Sciences figures

See a number that looks wrong?